Can I read Pseudomonas Aeruginosa: Piperacillin-Tazobactam Breakpoints For on EtoBox?
Pseudomonas Aeruginosa: Piperacillin-Tazobactam Breakpoints For by Alonso Antonio Arroyo is a document available to read on EtoBox.
What is Pseudomonas Aeruginosa: Piperacillin-Tazobactam Breakpoints For about?
This document discusses revising piperacillin-tazobactam breakpoints for Pseudomonas aeruginosa based on new pharmacokinetic and clinical data. It reviews the FDA-approved dosing schedules and commonly used dosages of piperacillin-tazobactam. Studies using modern pharmacokinetic/pharmacodynamic methods highlight low probability of target attainment at MICs >16 μg/mL. The CLSI working group evaluated available evidence to possibly revise breakpoints against P. aeruginosa.
- Author
- Alonso Antonio Arroyo
- Language
- EN